Please login to the form below

Not currently logged in

chronic lymphocytic leukemia

This page shows the latest chronic lymphocytic leukemia news and features for those working in and with pharma, biotech and healthcare.

Novartis scores promising phase 3 MS study

Novartis scores promising phase 3 MS study

The drug is already approved for the treatment of chronic lymphocytic leukemia (CLL), but if Novartis can gain approval for ofatumumab in MS, sales are likely to expand exponentially.  The positive

Latest news

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...